Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Combined Behavioral and Pharmacologic Treatment of Polydrug Abuse

This study has been completed.
Sponsor:
Information provided by:
National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:
NCT00292123
First received: February 14, 2006
Last updated: April 30, 2013
Last verified: December 2007

February 14, 2006
April 30, 2013
June 1999
June 2006   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00292123 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Combined Behavioral and Pharmacologic Treatment of Polydrug Abuse
Not Provided

The primary goal of this study is to determine how contingency management can best be combined with standard or high doses of methadone to increase simultaneous abstinence from heroin and cocaine.

A study of people pmaintained on Methadone using contingency management

Interventional
Phase 1
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator)
Primary Purpose: Treatment
  • Opioid Dependence
  • Cocaine Abuse
  • Drug: Methadone
  • Behavioral: Contingency Management
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
200
August 2006
June 2006   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Opioid dependence; cocaine use

Exclusion Criteria:

  • Medical or psychiatric conditions that would contraindicate participation in a methadone maintenance study; inability to give informed consent; inability to attend clinic seven days a week
Both
18 Years to 65 Years
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT00292123
NIDAIRP 326
No
Kenzie L. Preston, Ph.D., Principal Investigator, National Institute on Drug Abuse
National Institute on Drug Abuse (NIDA)
Not Provided
Principal Investigator: Kenzie Preston, PhD NIFA Intramural Research Program
National Institute on Drug Abuse (NIDA)
December 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP